{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:23:38Z","timestamp":1794248618955,"version":"4.9.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,21]]},"abstract":"<jats:p>\n                    This study evaluates the clinical efficacy and safety of superficial temporal artery to middle cerebral artery (STA-MCA) bypass combined with encephalo-duro-arterio-synangiosis (EDAS) in the treatment of moyamoya disease. A total of 80 patients with moyamoya disease who were treated at our institution between January 2022 and January 2024 were enrolled and randomly assigned to 2 groups: a control group (n\u2005=\u200540) and an observation group (n\u2005=\u200540). The control group underwent EDAS, while the observation group received STA-MCA bypass in addition to EDAS. Surgical success rates, cerebral blood flow (CBF) efficacy markers, neurological function scores, and surgical safety were comprehensively assessed in both groups. The surgical success rate in the observation group was 95.00%, significantly higher than 75.00% in the control group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Three days postoperatively, the observation group exhibited significantly higher CBF and cerebral blood volume compared to the control group, with reduced time to peak and mean transit time (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). One month after surgery, the observation group had significantly lower modified Rankin Scale and National Institutes of Health Stroke Scale scores, and higher mini-mental state examination scores compared to the control group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). The incidence of perioperative complications was 15.00% in the observation group and 17.50% in the control group, with no significant difference between the groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). STA-MCA bypass combined with EDAS significantly improves surgical success rates, cerebral hemodynamic parameters, and neurological function outcomes in patients with moyamoya disease without increasing the incidence of surgical complications, indicating favorable safety.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000041769","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T02:14:32Z","timestamp":1743041672000},"page":"e41769","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Safety analysis of STA-MCA bypass combined with EDAS in the treatment of patients with moyamoya disease"],"prefix":"10.1097","volume":"104","author":[{"given":"Chao","family":"Zhu","sequence":"first","affiliation":[{"name":"Neurosurgery Department, Pu\u2019er People\u2019s Hospital, Pu\u2019er, Yunnan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Wang","sequence":"additional","affiliation":[{"name":"Neurosurgery Department, Pu\u2019er People\u2019s Hospital, Pu\u2019er, Yunnan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3708-2658","authenticated-orcid":false,"given":"Junnan","family":"Li","sequence":"additional","affiliation":[{"name":"Neurosurgery Department, Pu\u2019er People\u2019s Hospital, Pu\u2019er, Yunnan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261109","first-page":"e84","article-title":"Response by Dula et al to letter regarding article, \u201cNeuroimaging in ischemic stroke is different between men and women in the DEFUSE 3 cohort\u201d.","volume":"51","author":"Dula","year":"2020","journal-title":"Stroke"},{"key":"R2-20261109","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","article-title":"Moyamoya disease: diagnosis and interventions.","volume":"21","author":"Ihara","year":"2022","journal-title":"Lancet Neurol"},{"key":"R3-20261109","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5853\/jos.2015.01627","article-title":"Moyamoya disease: epidemiology, clinical features, and diagnosis.","volume":"18","author":"Kim","year":"2016","journal-title":"J Stroke"},{"key":"R4-20261109","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/1570159X19666210716114016","article-title":"Progression in moyamoya disease: clinical features, neuroimaging evaluation, and treatment.","volume":"20","author":"Zhang","year":"2022","journal-title":"Curr Neuropharmacol"},{"key":"R5-20261109","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13023-019-1137-y","article-title":"Rare diseases in China: analysis of 2014\u20132015 hospitalization summary reports for 281 rare diseases from 96 tertiary hospitals.","volume":"14","author":"Shi","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"R6-20261109","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10143-018-0994-5","article-title":"Progress in moyamoya disease.","volume":"43","author":"Shang","year":"2020","journal-title":"Neurosurg Rev"},{"key":"R7-20261109","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1177\/0271678X241226483","article-title":"Intraoperative evaluation of local cerebral hemodynamic change by laser speckle contrast imaging for predicting postoperative cerebral hyperperfusion during STA-MCA bypass in adult patients with moyamoya disease.","volume":"44","author":"Tao","year":"2024","journal-title":"J Cereb Blood Flow Metab"},{"key":"R8-20261109","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3171\/2019.10.JNS191207","article-title":"Hemodynamic analysis of the recipient parasylvian cortical arteries for predicting postoperative hyperperfusion during STA-MCA bypass in adult patients with moyamoya disease.","volume":"134","author":"Zhang","year":"2019","journal-title":"J Neurosurg"},{"key":"R9-20261109","first-page":"126","article-title":"Surgical treatment of adult moyamoya disease with combined STA-MCA bypass and EDAS: demonstration of technique in video presentation.","volume":"25","author":"Li","year":"2015","journal-title":"Turk Neurosurg"},{"key":"R10-20261109","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/jnnp.2007.130666","article-title":"Novel epidemiological features of moyamoya disease.","volume":"79","author":"Baba","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R11-20261109","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3171\/2024.1.JNS221977","article-title":"Management of moyamoya disease: a review of current and future therapeutic strategies.","volume":"141","author":"Kappel","year":"2024","journal-title":"J Neurosurg"},{"key":"R12-20261109","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","article-title":"Moyamoya disease: current concepts and future perspectives.","volume":"7","author":"Kuroda","year":"2008","journal-title":"Lancet Neurol"},{"key":"R13-20261109","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nec.2017.02.004","article-title":"Direct versus indirect bypass for moyamoya disease.","volume":"28","author":"Liu","year":"2017","journal-title":"Neurosurg Clin N Am"},{"key":"R14-20261109","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/1747493017694393","article-title":"Etiology and pathogenesis of moyamoya disease: an update on disease prevalence.","volume":"12","author":"Huang","year":"2017","journal-title":"Int J Stroke"},{"key":"R15-20261109","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1097\/CM9.0000000000002985","article-title":"RNF213 in moyamoya disease: genotype-phenotype association and the underlying mechanism.","volume":"137","author":"Fang","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"R16-20261109","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12975-021-00940-2","article-title":"The genetic basis of moyamoya disease.","volume":"13","author":"Mertens","year":"2022","journal-title":"Transl Stroke Res"},{"key":"R17-20261109","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.3171\/2011.3.FOCUS1151","article-title":"Moyamoya disease: a review of histopathology, biochemistry, and genetics.","volume":"30","author":"Weinberg","year":"2011","journal-title":"Neurosurg Focus"},{"key":"R18-20261109","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1161\/STR.0000000000000443","article-title":"Adult moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the American Heart Association\/American Stroke Association.","volume":"54","author":"Gonzalez","year":"2023","journal-title":"Stroke"},{"key":"R19-20261109","doi-asserted-by":"crossref","first-page":"277","DOI":"10.23736\/S0390-5616.20.05079-1","article-title":"Flow-augmentation bypass for moyamoya disease.","volume":"65","author":"Fujimura","year":"2021","journal-title":"J Neurosurg Sci"},{"key":"R20-20261109","doi-asserted-by":"crossref","first-page":"1273822","DOI":"10.3389\/fneur.2023.1273822","article-title":"Clinical effect of a modified superficial temporal artery-middle cerebral artery bypass surgery in moyamoya disease treatment.","volume":"14","author":"Lu","year":"2023","journal-title":"Front Neurol"},{"key":"R21-20261109","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3171\/2020.9.JNS202362","article-title":"Coding cerebral bypasses: a proposed nomenclature to better describe bypass constructs and revascularization techniques.","volume":"136","author":"Tayebi Meybodi","year":"2022","journal-title":"J Neurosurg"},{"key":"R22-20261109","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.sjbs.2019.12.016","article-title":"Therapeutic effect of autologous bone marrow stem cell mobilization combined with anti-infective therapy on moyamoya disease.","volume":"27","author":"Zhao","year":"2020","journal-title":"Saudi J Biol Sci"},{"key":"R23-20261109","doi-asserted-by":"crossref","first-page":"661611","DOI":"10.3389\/fneur.2023.661611","article-title":"Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases.","volume":"14","author":"Dorschel","year":"2023","journal-title":"Front Neurol"},{"key":"R24-20261109","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/TACG.S252736","article-title":"Genetic and proteomic contributions to the pathophysiology of moyamoya angiopathy and related vascular diseases.","volume":"14","author":"Dorschel","year":"2021","journal-title":"Appl Clin Genet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:01:32Z","timestamp":1794247292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041769","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,21]]}}}